Valitic Hits 2 Million Customers, Boosting Innocan’s Consumer Wellness Play
Event summary
- Valitic, a skincare brand under Innocan Pharma’s subsidiary B.I. Sky Global, surpassed 2 million customers as of July 29, 2026.
- The milestone reflects strong growth across e-commerce platforms driven by data-driven digital marketing and product innovation.
- Innocan CEO Iris Bincovich framed the achievement as a step toward long-term shareholder value creation.
The big picture
Innocan Pharma’s Valitic brand is capitalizing on the booming U.S. skincare market, where digital-first brands are gaining traction through direct-to-consumer models. The milestone underscores the strategic shift from pharmaceuticals to wellness as a growth driver for Innocan, though it remains to be seen whether this consumer-focused play can sustain long-term profitability.
What we're watching
- Sustainable Growth
- Whether Valitic can maintain its rapid customer acquisition pace amid increasing competition in the U.S. beauty market.
- Market Expansion
- How Innocan leverages this milestone to expand Valitic’s presence beyond e-commerce into physical retail channels.
- Shareholder Value
- The pace at which Innocan translates consumer wellness growth into tangible financial returns for shareholders.